Braun Stacey Associates’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4M Buy
33,007
+2,202
+7% +$1.04M 0.54% 75
2025
Q4
$13.1M Buy
30,805
+835
+3% +$358K 0.43% 80
2025
Q3
$14.2M Buy
29,970
+1,653
+6% +$783K 0.47% 82
2025
Q2
$13.3M Buy
28,317
+716
+3% +$327K 0.48% 80
2025
Q1
$12.9M Sell
27,601
-99
-0.4% -$44.6K 0.53% 73
2024
Q4
$11.6M Buy
27,700
+10
+0% +$4.56K 0.43% 79
2024
Q3
$13.2M Buy
27,690
+238
+0.9% +$109K 0.5% 74
2024
Q2
$12M Buy
27,452
+2,224
+9% +$979K 0.47% 77
2024
Q1
$11.7M Sell
25,228
-21
-0.1% -$9.09K 0.46% 82
2023
Q4
$10.4M Buy
25,249
+6,782
+37% +$2.67M 0.46% 83
2023
Q3
$6.88M Buy
+18,467
New +$7.03M 0.33% 87

Other funds holding LIN

Braun Stacey Associates's LIN Position: Q1 2026 in Review

Braun Stacey Associates increased its Linde (LIN) stake by 7.1% in Q1 2026, buying an estimated $1.04M and bringing the position to 33,007 shares worth $16.4M. The position accounts for 0.54% of the portfolio, ranked #75.

Braun Stacey Associates first reported a position in LIN in Q3 2023 and has held it in 11 quarters since. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Braun Stacey Associates held 33,007 shares of Linde worth $16.4M as of Q1 2026.
  • Braun Stacey Associates bought 2,202 Linde shares in Q1 2026, an estimated $1.04M.
  • Linde made up 0.54% of Braun Stacey Associates's portfolio in Q1 2026, its #75 holding.
  • Braun Stacey Associates first reported a position in Linde in Q3 2023 and has held it in 11 quarters since.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.